AJOVista LLC Makes New Investment in Quanterix Co. (NASDAQ:QTRX)

AJOVista LLC acquired a new position in Quanterix Co. (NASDAQ:QTRX) in the fourth quarter, HoldingsChannel reports. The fund acquired 2,971 shares of the company’s stock, valued at approximately $81,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Gotham Asset Management LLC bought a new position in Quanterix in the third quarter worth approximately $423,000. Lord Abbett & CO. LLC purchased a new stake in shares of Quanterix during the 3rd quarter worth $27,744,000. Strs Ohio boosted its position in Quanterix by 5.7% during the fourth quarter. Strs Ohio now owns 18,400 shares of the company’s stock valued at $503,000 after purchasing an additional 1,000 shares in the last quarter. Vanguard Group Inc. grew its stake in Quanterix by 1.4% in the third quarter. Vanguard Group Inc. now owns 1,997,295 shares of the company’s stock valued at $54,207,000 after purchasing an additional 26,660 shares during the last quarter. Finally, Emerald Mutual Fund Advisers Trust raised its holdings in Quanterix by 353.4% in the third quarter. Emerald Mutual Fund Advisers Trust now owns 313,044 shares of the company’s stock worth $8,496,000 after purchasing an additional 243,994 shares in the last quarter. 86.48% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several equities analysts have issued reports on the stock. Scotiabank lifted their price target on shares of Quanterix from $30.00 to $32.00 and gave the stock a “sector outperform” rating in a report on Monday, March 4th. Canaccord Genuity Group lowered their price target on Quanterix from $32.00 to $25.00 and set a “buy” rating for the company in a report on Monday, April 29th. Five equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Buy” and an average target price of $30.60.

Quanterix Stock Up 0.6 %

QTRX stock traded up $0.10 during midday trading on Friday, hitting $17.02. 367,415 shares of the stock traded hands, compared to its average volume of 397,240. The stock’s fifty day simple moving average is $21.81 and its 200-day simple moving average is $23.15. Quanterix Co. has a 1-year low of $15.32 and a 1-year high of $29.70.

Quanterix (NASDAQ:QTRX) last released its quarterly earnings results on Thursday, February 29th. The company reported ($0.33) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.28) by ($0.05). Quanterix had a negative return on equity of 9.15% and a negative net margin of 26.42%. The business had revenue of $31.55 million during the quarter, compared to analyst estimates of $27.92 million. On average, research analysts forecast that Quanterix Co. will post -1.04 EPS for the current year.

Insiders Place Their Bets

In other news, Director Laurie J. Olson sold 1,500 shares of the business’s stock in a transaction dated Wednesday, February 14th. The shares were sold at an average price of $24.35, for a total transaction of $36,525.00. Following the completion of the sale, the director now owns 15,238 shares of the company’s stock, valued at $371,045.30. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 6.80% of the stock is currently owned by company insiders.

Quanterix Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.